As of 2025-09-17, the Intrinsic Value of Molecule Holdings Inc (MLCL.CN) is -0.22 CAD. This MLCL.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.01 CAD, the upside of Molecule Holdings Inc is -4,436.57%.
Based on its market price of 0.01 CAD and our intrinsic valuation, Molecule Holdings Inc (MLCL.CN) is overvalued by 4,436.57%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
Range | Selected | Upside | |
a | |||
Fair Value | -0.22 - -0.22 | -0.22 | -4,436.57% |
P/E | (0.05) - (0.09) | (0.05) | -1097.4% |
DDM - Stable | (0.09) - (0.35) | (0.22) | -4503.1% |
DDM - Multi | 0.00 - 0.00 | 0.00 | -100.0% |
Market Cap (mil) | 0.48 |
Beta | 1.39 |
Outstanding shares (mil) | 95.38 |
Enterprise Value (mil) | 5.93 |
Market risk premium | 5.10% |
Cost of Equity | 26.13% |
Cost of Debt | 5.00% |
WACC | 5.58% |